|
| Uridine-13C9-15N2 5'-(tetrahydrogen triphosphate) sodium salt Basic information |
Product Name: | Uridine-13C9-15N2 5'-(tetrahydrogen triphosphate) sodium salt | Synonyms: | UTP.Na2;5′-UTP,2Na;uridine-13c9,15n2 5-triphosphate disodium salt;Uridine-13C9-15N2 5'-(tetrahydrogen triphosphate) sodium salt;Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogentriphosphate;URIDINE-13C9, 15N2-5 TRIPHOSPHATE SODI U;URIDINE-13C9 15N2-5' TRIPHOSPHATE SODI UM SALT 96 ATOM % 13C 99 ATOM % 15N;Uridine-913C-2-15N 5μ-triphosphate sodium salt | CAS: | 285978-18-9 | MF: | C9H13N2O15P3.2Na | MW: | 528.103 | EINECS: | 2017-001-1 | Product Categories: | Material;Pharmaceutical | Mol File: | 285978-18-9.mol | |
| Uridine-13C9-15N2 5'-(tetrahydrogen triphosphate) sodium salt Chemical Properties |
Melting point | >199?C (dec.) | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | solubility | Water (Slightly) | form | Solid | color | White to Off-White | Water Solubility | Water : 125 mg/mL (231.90 mM; Need ultrasonic) | Stability: | Hygroscopic |
| Uridine-13C9-15N2 5'-(tetrahydrogen triphosphate) sodium salt Usage And Synthesis |
Uses | Uridine 5’-Triphosphate-13C9,15N2 Sodium Salt is the labelled form of the nucleotide UTP (CAS# 63-39-8) used for diagnosis of stenoses and other conditions of restricted blood flow. |
| Uridine-13C9-15N2 5'-(tetrahydrogen triphosphate) sodium salt Preparation Products And Raw materials |
|